Sign inCreate account

Report workspace tools

NCT01658748WITHDRAWNanonymous

A Pilot Study to Examine Deep Brain Stimulation (DBS) in the Basolateral Nucleus (BLn) of the Amygdala for the Management of Symptoms in Veterans With Chronic and Treatment-Refractory Combat-related Post-Traumatic Stress Disorder (PTSD)

Sponsor

Source record

US Department of Veterans Affairs

Phase

Source record

Withdrawn

Modality

AI-normalized

gene therapy

Target

AI-normalized

Post-Traumatic Stress Disorder (PTSD)

Indication / condition

AI-normalized

Post Traumatic Stress Disorder

Intervention

Source record

Week 0 Medtronic 3387 electrodes/Activa PC amygdala DBS, Week 12 Medtronic 3387 electrodes/Activa PC amygdala DBS

Source & freshness

Source record

NCT ID

NCT01658748

Original source

ClinicalTrials.gov

Source last updated

May 29, 2013

Ingested at

May 30, 2026

Internal sync

Jun 05, 2026

Model version

trialsignal-ai-v1

Normalized confidence

88%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT01658748

Title

A Pilot Study to Examine Deep Brain Stimulation (DBS) in the Basolateral Nucleus (BLn) of the Amygdala for the Management of Symptoms in Veterans With Chronic and Treatment-Refractory Combat-related Post-Traumatic Stress Disorder (PTSD)

Sponsor

US Department of Veterans Affairs

Status

WITHDRAWN

Phase

Withdrawn

Condition raw

Post Traumatic Stress Disorder

Condition normalized

Post Traumatic Stress Disorder

Modality raw

Post Traumatic Stress Disorder

Modality normalized

gene therapy

Target raw

Post-Traumatic Stress Disorder (PTSD)

Target normalized

Post-Traumatic Stress Disorder (PTSD)

Interventions

Week 0 Medtronic 3387 electrodes/Activa PC amygdala DBS, Week 12 Medtronic 3387 electrodes/Activa PC amygdala DBS

Public preview

Source record

This pilot study aimed to evaluate the safety and efficacy of deep brain stimulation (DBS) targeting the basolateral nucleus of the amygdala in veterans with treatment-refractory PTSD. The study was sponsored by the US Department of Veterans Affairs and intended to recruit combat veterans suffering from severe PTSD symptoms despite existing treatment options.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account
Sign in

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

A Pilot Study to Examine Deep Brain Stimulation (DBS) in the Basolateral Nucleus (BLn) of the Amygdala for the Management of Symptoms in Veterans With Chronic and Treatment-Refractory Combat-related Post-Traumatic Stress Disorder (PTSD)

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 13, 2026

NCT ID

NCT01658748

Status

WITHDRAWN

Phase

Withdrawn

Sponsor

US Department of Veterans Affairs

Executive brief

Investment-Ready Snapshot

This pilot study aimed to evaluate the safety and efficacy of deep brain stimulation (DBS) targeting the basolateral nucleus of the amygdala in veterans with treatment-refractory PTSD. The study was sponsored by the US Department of Veterans Affairs and intended to recruit combat veterans suffering from severe PTSD symptoms despite existing treatment options.

Source & freshness

Provenance

SourceClinicalTrials.gov
Source updatedMay 29, 2013
Internal syncJun 05, 2026
Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT01658748

Indication

Post Traumatic Stress Disorder

Modality

gene therapy

Target

Post-Traumatic Stress Disorder (PTSD)

Intervention

Week 0 Medtronic 3387 electrodes/Activa PC amygdala DBS, Week 12 Medtronic 3387 electrodes/Activa PC amygdala DBS

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.